Recent Securities Litigations

Spectrum Pharmaceuticals Inc.Common Stock (NASDAQ: SPPI)

38 Days left to seek lead plaintiff status.

Company Name:Spectrum Pharmaceuticals Inc.Common Stock
Stock Symbol:NASDAQ: SPPI
Class Period Start:12/27/2018
Class Period End (inclusive):08/05/2021
Filing Deadline:11/01/2021

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose that: (i) the ROLONTIS manufacturing facility maintained deficient controls and/or procedures; (ii) the foregoing deficiencies decreased the likelihood that the FDA would approve the ROLONTIS BLA in its current form; (iii) Spectrum had therefore materially overstated the ROLONTIS BLA's approval prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Spectrum Pharmaceuticals Inc.Common Stock (NASDAQ: SPPI) Claim Form

Name(Required)
Address
Consent(Required)
This field is for validation purposes and should be left unchanged.